Sneddon syndrome

ICD-10: M30.8MeSH: D018860ORPHA: 8202 Treatments Available

Contents

1. Overview
2. Available Treatments
3. Clinical Presentation
4. Classification & Codes

Overview

form of arteriopathy

Available Treatments (2)

Drug	Form	Status	Countries	Lead Time
aspirin	Oral tablet, 81mg, 325mg	FDA Approved	12	1d
warfarin	Oral tablet, 1mg, 2mg, 2.5mg, 3mg, 4mg, 5mg, 6mg, 7.5mg, 10mg	FDA Approved	9	3d

Clinical Presentation

Signs and symptoms associated with Sneddon syndrome, sourced from HPO and Orphanet clinical annotations.

Atypical behaviorCutis marmorataThromboembolic strokeMigraineCerebral cortical atrophyHeadacheVertigoMemory impairmentSensorimotor neuropathyVascular skin abnormalityArterial stenosisDementiaHypertensionVisual field defectMental deteriorationHemiparesisMotor delayMuscle weaknessMitral regurgitationAortic regurgitationTransient ischemic attackDevelopmental regressionFocal-onset seizureImpaired visuospatial constructive cognitionLibman-Sacks lesionsDecreased glomerular filtration rateCerebral infarctDiminished ability to concentrateCognitive impairmentAmaurosis fugaxProteinuriaNephropathyDepressionSeizureTremorBicuspid aortic valveChoreaIntracranial hemorrhageAphasiaAntiphospholipid antibody positivityChilblainsPeripheral neuropathyOculomotor nerve palsyCentral retinal vein occlusionCentral retinal artery occlusionInternuclear ophthalmoplegiaRaynaud phenomenonCutaneous necrosisCerebral visual impairmentSuicide behaviorsSplinter hemorrhagesSubarachnoid hemorrhageIntraventricular hemorrhageLivedo racemosaInflammation

Classification & Codes

ICD-10 Code

M30.8

MeSH Code

D018860

Orphanet Code

ORPHA:820

Sneddon syndrome

ICD-10	`M30.8`
MeSH	`D018860`
Orphanet	`ORPHA:820`
Treatments	2 drug(s)
Symptoms on record	55 signs
Status	published

Treatment Summary

aspirin warfarin

Factual Authority

Last Updated3/20/2026

Clinical DataHPO · Orphanet

Drug DataFDA · EMA · CDSCO